| [1] |
WANG Junda, LENG Jing, YANG yalin, LI Yanyan.
Analysis and treatment of adverse reactions associated with four gadolinium contrast agents
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(9): 1056-1062.
|
| [2] |
LU Qing，ZENG Qingzhang, ZHOU Yaping, YU Peiming, LI Haona.
Analysis of adverse drug events of everolimus based on US FAERS database
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2018, 23(5): 547-551.
|
| [3] |
MA Xiao-qin, XIN Hua-wen, LI Yuan-qi, HUANG Hui, ZHAO Li, YU Ai-rong, LI Wei-liang, WU Xiao-chun.
Association of HGPRT activity and gene polymorphism with adverse reactions caused by azathioprine in kidney transplant recipients
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2015, 20(2): 182-187.
|
| [4] |
WANG Lin, QIU Xiao-yan.
Retrospective analysis of 119 cases with severe drug eruption
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(8): 885-889.
|
| [5] |
HU Hua, XIE Hai-tang, XU Zhe, PU Zhi-cheng, CHEN Qun, SUN Hua, ZHANG Xue-feng.
Development of ADRCAS ——adverse drug reactions comprehensive analysis system
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(6): 712-716.
|
| [6] |
YANG Xiao-jun, XIE Hai-tang, XU Wen-ke, JIAYuan-wei, ZHANG Wen.
Study on awareness of adverse drug reactions and Safe Drug Use knowledge among three kinds of medical stuff in a certain 3A-grade hospital
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2013, 18(9): 1008-1013.
|
| [7] |
CHEN Bing, CAI Wei-min, YANG Wan-hua.
Genetic polymorphism of CYP2D6 and its influence on the personalized usage of antipsychotics
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2012, 17(9): 1067-1074.
|
| [8] |
CHEN Wang-qing, ZHANG Wei.
Mechanism of pharmacogenetics on drug withdrawal
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2011, 16(9): 1065-1071.
|
| [9] |
ZHOU She-dian, LIANG Ping, ZHOU Gan-ping, CHEN Yu-qiang, LI Song.
Retrospective analysis of the 258 adxerse drug reaction cases in our hospital
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2008, 13(6): 690-693.
|
| [10] |
YANG Li-jie, LI Xiao-meng, GUO Mei-hua.
Analysis of adverse effects of fosfomycin injection in 148 cases
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2008, 13(3): 320-322.
|
| [11] |
ZHANG Fan.
Adverse drug reaction reports in our hospital: survey of 202 cases
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2007, 12(6): 718-720.
|
| [12] |
LI Xian-tao, LIANG Wei-xiong, WANG Qi, WEN Ze-huai.
Values of interim analysis in drug clinical trials studies
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2005, 10(1): 112-115.
|
| [13] |
XIANG Nan, HU You-Zhi, SHI Jie, ZHANG Feng, FENG De-Xun.
Efficacy and safety of xindakang capsules in treatment of patients with angina pectoris
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2004, 9(9): 1033-1036.
|
| [14] |
HU You-Zhi, SHI Jie, XIANG Nan, ZHANG Feng, WANG Yan-Li, Feng DE-Xun, DENG A-Li.
Efficacy and safety of xuesetong pills in the treatment of patients with angina pectoris
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2004, 9(10): 1168-1171.
|
| [15] |
Xu Feng, Wu Zhaohui, Zhang Zhongyi, Zou Hengqing.
Concentration-dependent effect of cyclosporine on plasma lipid in renal transplant recipients
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 1997, 2(3): 165-168.
|
